Influence of pre‐operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta‐analysis
- 30 April 2014
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 24 (3) , 237-245
Abstract
Purpose: Serotonergic antidepressants (SADs) are one of the most widely prescribed group of drugs. Of late, the use of SADs is being associated with an increased risk of perioperative bleeding. However, the results are inconsistent. The present analysis was planned to evaluate the association between preoperative SADs use and the risk of bleeding/mortality in patients undergoing surgery.Methods: Studies that had reported the effects of preoperative SADs use on the perioperative bleeding outcomes and/or mortality in adult patients undergoing surgical interventions were identified and evaluated for inclusion in the analysis. Outcomes evaluated were reoperation for bleeding event, requirement of blood/RBC transfusion and mortality. A meta‐analysis was conducted, and a pooled estimate of odds ratio (OR) was calculated using the inverse variance method.Results: Eight cohort studies, comprising a total of 79 976 SADs users and 485 336 non‐antidepressant users were included in the final analysis. SADs use was not associated with increased risk of requirement of reoperation for bleeding event [OR = 1.48 (0.84−2.62)]. However, there was an increased requirement of transfusion [OR = 1.19(1.09−1.30)], which was not observed in the subgroup of patients undergoing coronary artery bypass graft (CABG) [OR = 1.06(0.90−1.24)]. SADs use was associated with a substantial increase in mortality [OR = 1.53 (1.15−2.04)] in patients undergoing CABG but not in the overall population [OR = 1.1 (0.99−1.22)].Conclusions: Preoperative SADs use is associated with increased bleeding risk with respect to requirement of transfusion; nevertheless, the results should not be generalized to all surgical groups. The divergence between bleeding risk and mortality in CABG surgery patients needs further evaluation.Keywords
This publication has 30 references indexed in Scilit:
- Bleeding Incidence With Concomitant Use of Antidepressants and WarfarinTherapeutic Drug Monitoring, 2011
- Effects of Selective Serotonin Reuptake Inhibitors on Platelet FunctionDrugs & Aging, 2011
- Use of Serotonergic Antidepressants and Bleeding Risk in Orthopedic PatientsAnesthesiology, 2010
- Visualizing Pharmacological Activities of Antidepressants: A Novel ApproachThe Open Pharmacology Journal, 2008
- Meta‐analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non‐steroidal anti‐inflammatory drugsAlimentary Pharmacology & Therapeutics, 2007
- Effect of Selective Serotonin Reuptake Inhibitors on Requirement for Allogeneic Red Blood Cell Transfusion Following Coronary Artery Bypass SurgeryAmerican Journal of Cardiovascular Drugs, 2006
- The influence of selective serotonin reuptake inhibitors on human platelet serotoninThrombosis and Haemostasis, 2004
- Relationship of Serotonergic Antidepressants and Need for Blood Transfusion in Orthopedic Surgical PatientsArchives of internal medicine (1960), 2003
- Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerabilityJournal of Affective Disorders, 2000
- The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.Journal of Epidemiology and Community Health, 1998